Association Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy and Survival Among Children With Favorable-Risk Hodgkin LymphomaMonika L. Metzger, Michael P. Link, Jianrong Wu et al.|JAMA|2012Cited by 113
Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node RadiationMonika L. Metzger, Matthew J. Krasin, Michael P. Link et al.|Journal of Clinical Oncology|2021Cited by 59
Relapse after treatment of pediatric hodgkin lymphoma: Outcome and role of surveillance after end of therapyAlison M. Friedmann, Monika L. Metzger, Julie Wolfson et al.|Pediatric Blood & Cancer|2013Cited by 32
Stanford V chemotherapy and involved field radiotherapy for children and adolescents with unfavorable risk Hodgkin lymphoma: Results of a multi-institutional prospective clinical trial.Monika L. Metzger, Melissa M. Hudson, Amy L. Billett et al.|Journal of Clinical Oncology|2012Cited by 7
Dose-dense chemotherapy enables elimination of RT for the majority of low-risk pediatric Hodgkin lymphomas: PHC study HOD08Jamie E. Flerlage, M Link, Angela M. Feraco et al.|Blood|2026Cited by 2